Stocks · Health care · Pharmaceutical Preparations

Vera Therapeutics, Inc.

VERA Clue Score36
United States Fiscal year ends December CIK 0001831828 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Marshall Fordyce
15 Sep 2026
President and CEO
Sold after exercise
18,500
$37.00
$684.50K
Marshall Fordyce
2 Sep 2026
President and CEO
Sold after exercise
18,500
$35.12
$649.64K
William D. Turner
15 Dec 2025
Chief Regulatory Officer
Sold after exercise
10,000
$50.08
$500.77K
William D. Turner
8 Dec 2025
Chief Regulatory Officer
Sold after exercise
10,000
$45.31
$453.05K
William D. Turner
3 Dec 2025
Chief Regulatory Officer
Sold after exercise
10,000
$40.00
$400.00K

What was left out

Form 4 filings counted 40
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 5
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 373,190
History held since 17 May 2021